The UCI has made the official announcement that no other doping sample taken during the Tour de France has returned a positive result after the complete analyses, leaving Luxembourgish rider Frank Schleck as the only rider in this year’s Tour de France to have a positive result in the dope tests. The governing body of cycling made a statement where they claimed that the CADF or the Cycling Anti Doping Federation has received all the final and complete results of the random dope tests that were carried out during the event last July.

The samples that have been received from the laboratories of Lausanne, Chatenay-Malabry, as well as Cologne have all showed negative results, according to a stamen that has been released by the governing body of cycling. However, this news comes after it was confirmed that Frank Schleck of Team Radio Shack Nissan had returned a positive sample to his dope test after the 13th stage of the Tour de France that was held in July, 2012.

The 32 year old cyclist from Luxembourg was found guilty of having Xipamid, a diuretic in his system. This substance is included in the list of banned substances by the World Anti Doping Agency or the WADA, which can be used sometimes as a masking agent. The 32 year old, however, denied that he had taken any performance enhancing drug during or before the Tour de France. His B-sample was also found to have returned with the same positive result.

He has been sanctioned from racing further this year, meaning Frank Schleck will not be able to race at the USA Pro Cycling Challenge that is taking place currently and his case has also been referred to the Luxembourg Anti Doping Agency which forwarded it to the disciplinary committee, where Schleck awaits a hearing.